1991•PubMedRequires access

Clozapine and jaw dyskinesia: a case report.

José de León, Laura Doménech Moral, C Camuñas

Open publisher page 29 citations

Abstract

No convincing case of tardive dyskinesia has been associated with clozapine. We briefly discuss a case of clozapine-induced reversible initial dyskinesia described in the German literature, and we report a case of jaw dyskinesia in a 49-year-old female schizophrenic. The dyskinesia appeared 2 weeks after the patient started clozapine treatment, did not respond to anticholinergic medication, and has continued for more than 1 year while the patient has remained on clozapine treatment. The patient had taken haloperidol (less than or equal to 5 mg/day) for 5 weeks before starting clozapine treatment. These are the only two cases of dyskinesia associated with clozapine use that are known to us. They raise the possibility that clozapine can induce dyskinesia.

About this research paper

What this paper is about

No convincing case of tardive dyskinesia has been associated with clozapine. We briefly discuss a case of clozapine-induced reversible initial dyskinesia described in the German literature, and we report a case of jaw dyskinesia in a 49-year-old female schizophrenic. The dyskinesia appeared 2 weeks after the patient started clozapine treatment, did not respond to anticholinergic medication, and has continued for more than 1 year while the patient has remained on clozapine treatment. The patient had taken haloperidol (less than or equal to 5 mg/day) for 5 weeks before starting clozapine treatment. These are the only two cases of dyskinesia associated with clozapine use that are known to us. They raise the possibility that clozapine can induce dyskinesia.

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

No convincing case of tardive dyskinesia has been associated with clozapine. We briefly discuss a case of clozapine-induced reversible initial dyskinesia described in the German literature, and we report a case of jaw dyskinesia in a 49-year-old female schizophrenic. The dyskinesia appeared 2 weeks after the patient started clozapine treatment, did not respond to anticholinergic medication, and has continued for more than 1 year while the patient has remained on clozapine treatment. The patient had taken haloperidol (less than or equal to 5 mg/day) for 5 weeks before starting clozapine treatment. These are the only two cases of dyskinesia associated with clozapine use that are known to us. They raise the possibility that clozapine can induce dyskinesia.

Key concepts: Clozapine, Dyskinesia, Tardive dyskinesia, Medicine, Haloperidol, Anesthesia, Pediatrics, Schizophrenia (object-oriented programming)

Related papers

Back to paper searchBrowse research topicsOriginal source
Clozapine and jaw dyskinesia: a case report. — Research Paper | ScholarLens